FOLD - Amicus Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.50
DETAILS
HIGH:
$14.50
LOW:
$14.50
MEDIAN:
$14.50
CONSENSUS:
$14.50
UPSIDE:
0.07%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 87.3% |
| EBIT Margin | 7.3% |
| EBITDA Margin | 8.5% |
| Operating Margin | 5.4% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | -4.3% |
| Net Margin | -4.3% |
| Bottom Line Margin | -4.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.84 |
| Quick Ratio | 1.88 |
| Solvency Ratio | -0.029 |
| Cash Ratio | 0.90 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-161.97
Peers avg: 24.5
|
| PEG Ratio | 3.17 |
| Forward PEG | 3.17 |
| Price/Book | 16.01 |
| Price/Sales | 6.92 |
| Price/FCF | 147.11 |
| Price/Op Cash Flow | 132.48 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.5088 |
| Debt/Equity | 1.7624 |
| Debt/Capital | 0.6380 |
| Long-Term Debt/Capital | 0.6126 |
| Financial Leverage | 3.46 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.60 |
| Operating Cash Flow Ratio | 0.139 |
| Operating Cash Flow/Sales | 5.2% |
| Free Cash Flow/Operating Cash Flow | 90.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.48 |
| Interest Coverage | 0.7472 |
| Short-Term Operating Cash Flow Coverage | 3.79 |
| Operating Cash Flow Coverage | 0.07 |
| Capital Expenditure Coverage | 10.06 |
| Dividend + Capital Expenditure Coverage | 10.06 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.06 |
| EPS | -0.088 |
| Debt/Share | 1.7171 |
| Cash/Share | 0.95 |
| Book Value/Share | 0.89 |
| Tangible BV/Share | 0.20 |
| Equity/Share | 0.89 |
| Operating Cash Flow/Share | 0.107 |
| Capital Expenditure/Share | 0.011 |
| FCF/Share | 0.097 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | -141.937 |
| Earnings Before Tax/EBIT | 0.006 |
| Price/Fair Value | 16.01 |
| Debt/Market Cap | 0.1007 |
| Effective Tax Rate | 14293.7% |
| Enterprise Value Multiple | 86.61 |